Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s stock price hit a new 52-week high on Monday . The stock traded as high as $75.00 and last traded at $75.00, with a volume of 380 shares trading hands. The stock had previously closed at $71.20.
Analyst Ratings Changes
Separately, Chardan Capital upgraded shares of Pharma Mar to a “strong-buy” rating in a research note on Thursday, August 1st.
Get Our Latest Research Report on Pharma Mar
Pharma Mar Price Performance
About Pharma Mar
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
See Also
- Five stocks we like better than Pharma Mar
- Golden Cross Stocks: Pattern, Examples and Charts
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What is the NASDAQ Stock Exchange?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Manufacturing Stocks Investing
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
